Additive growth inhibitory effects of ibandronate and antiestrogens in estrogen receptor-positive breast cancer cell lines
2006

Ibandronate and Antiestrogens Work Together Against Breast Cancer Cells

publication Evidence: moderate

Author Information

Author(s): Fabrice Journe, Carole Chaboteaux, Nicolas Magne, Hugues Duvillier, Guy Laurent, Jean-Jacques Body

Primary Institution: Institut J Bordet, Centre des Tumeurs de l'Université Libre de Bruxelles, Brussels, Belgium

Hypothesis

Does ibandronate enhance the effects of antiestrogens in estrogen receptor-positive breast cancer cells?

Conclusion

Ibandronate shows additive effects with antiestrogens in inhibiting the growth of estrogen receptor-positive breast cancer cells.

Supporting Evidence

  • Ibandronate inhibited cancer cell growth in a dose- and time-dependent manner.
  • It completely abolished the mitogenic effect induced by 17β-estradiol in ER+ breast cancer cells.
  • Ibandronate enhanced the growth inhibitory action of antiestrogens in estrogen-sensitive breast cancer cells.

Takeaway

Ibandronate can help stop breast cancer cells from growing, especially when used with other cancer-fighting drugs called antiestrogens.

Methodology

The study examined the effects of ibandronate on breast cancer cell lines in steroid-free medium and assessed its interaction with antiestrogens.

Limitations

The study was conducted in vitro, which may not fully replicate in vivo conditions.

Statistical Information

P-Value

p<0.01

Statistical Significance

p<0.01

Digital Object Identifier (DOI)

10.1186/bcr1363

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication